Literature DB >> 19822165

PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships.

Andrea Beyerle1, Olivia Merkel, Tobias Stoeger, Thomas Kissel.   

Abstract

Poly(ethylene imine) (PEI) has widely been used as non-viral gene carrier due to its capability to form stable complexes by electrostatic interactions with nucleic acids. To reduce cytotoxicity of PEI, several studies have addressed modified PEIs such as block or graft copolymers containing cationic and hydrophilic non-ionic components. Copolymers of PEI and hydrophilic poly(ethylene glycol) (PEG) with various molecular weights and graft densities were shown to exhibit decreased cytotoxicity and potential for DNA and siRNA delivery. In this study, we evaluated the cytotoxicity and cell-compatibility of different PEGylated PEI polymers in two murine lung cell lines. We found that the degree of PEGylation correlated with both cytotoxicity and oxidative stress, but not with proinflammatory effects. AB type copolymers with long PEG blocks caused high membrane damage and significantly decreased the metabolic activity of lung cells. In addition, they significantly increased the release of two lipid mediators such as 8-isoprostanes (8-IP) and prostaglandin E(2) (PGE(2)) in a dose-dependent manner. In contrast, the cytokine profiles which indicated high levels of acute-phase cytokines such as TNF-alpha, IL-6, and G-CSF did not follow any clear structure-function relationship. In conclusion, we found that modification of PEI 25 kDa with high degree of PEGylation and low PEG chain length reduced cytotoxic and oxidative stress response in lung cells, while the proinflammatory potential remained unaffected. A degree of substitution in the range of 10 to 30 and PEG-chain lengths up to 2000 Da seem to be beneficial and merit further investigations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822165     DOI: 10.1016/j.taap.2009.10.001

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  16 in total

Review 1.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 2.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

3.  Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.

Authors:  Jung Soo Suk; Anthony J Kim; Kanika Trehan; Craig S Schneider; Liudmila Cebotaru; Owen M Woodward; Nicholas J Boylan; Michael P Boyle; Samuel K Lai; William B Guggino; Justin Hanes
Journal:  J Control Release       Date:  2014-01-14       Impact factor: 9.776

4.  Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.

Authors:  Najung Kim; Dahai Jiang; Ashley M Jacobi; Kim A Lennox; Scott D Rose; Mark A Behlke; Aliasger K Salem
Journal:  Int J Pharm       Date:  2011-08-12       Impact factor: 5.875

5.  Enhanced transfection by antioxidative polymeric gene carrier that reduces polyplex-mediated cellular oxidative stress.

Authors:  Min Sang Lee; Nak Won Kim; Kyuri Lee; Hongtae Kim; Ji Hoon Jeong
Journal:  Pharm Res       Date:  2013-03-30       Impact factor: 4.200

6.  Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells.

Authors:  Supang Khondee; Abdulgader Baoum; Teruna J Siahaan; Cory Berkland
Journal:  Mol Pharm       Date:  2011-04-22       Impact factor: 4.939

7.  PEGylated polyplex with optimized PEG shielding enhances gene introduction in lungs by minimizing inflammatory responses.

Authors:  Satoshi Uchida; Keiji Itaka; Qixian Chen; Kensuke Osada; Takehiko Ishii; Masa-Aki Shibata; Mariko Harada-Shiba; Kazunori Kataoka
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

8.  Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers.

Authors:  Anthony J Kim; Nicholas J Boylan; Jung Soo Suk; Minyoung Hwangbo; Tao Yu; Benjamin S Schuster; Liudimila Cebotaru; Wojciech G Lesniak; Joon Seok Oh; Pichet Adstamongkonkul; Ashley Y Choi; Rangaramanujam M Kannan; Justin Hanes
Journal:  Angew Chem Int Ed Engl       Date:  2013-03-04       Impact factor: 15.336

9.  Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery.

Authors:  Aoife M O'Mahony; Julien Ogier; Raphael Darcy; John F Cryan; Caitriona M O'Driscoll
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

10.  Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain.

Authors:  Panagiotis Mastorakos; Clark Zhang; Sneha Berry; Yumin Oh; Seulki Lee; Charles G Eberhart; Graeme F Woodworth; Jung Soo Suk; Justin Hanes
Journal:  Adv Healthc Mater       Date:  2015-03-11       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.